Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 3 | 2015 | 1668 | 0.680 |
Why?
|
| Heart Failure | 7 | 2023 | 10900 | 0.660 |
Why?
|
| Early Ambulation | 1 | 2018 | 44 | 0.630 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2023 | 581 | 0.620 |
Why?
|
| Patient Readmission | 3 | 2018 | 3114 | 0.600 |
Why?
|
| Heart-Assist Devices | 1 | 2023 | 1194 | 0.440 |
Why?
|
| Pleural Effusion | 1 | 2014 | 338 | 0.380 |
Why?
|
| Patient Care Management | 1 | 2014 | 306 | 0.380 |
Why?
|
| Workload | 1 | 2015 | 850 | 0.350 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 1076 | 0.270 |
Why?
|
| Medicine | 1 | 2014 | 946 | 0.270 |
Why?
|
| Liver Diseases | 1 | 2014 | 1253 | 0.260 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2266 | 0.260 |
Why?
|
| Drug-Eluting Stents | 1 | 2012 | 753 | 0.250 |
Why?
|
| Length of Stay | 1 | 2018 | 6309 | 0.250 |
Why?
|
| Terminology as Topic | 1 | 2012 | 1547 | 0.240 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2291 | 0.210 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 1965 | 0.200 |
Why?
|
| Echocardiography | 1 | 2014 | 5102 | 0.200 |
Why?
|
| Radiology | 1 | 2014 | 2100 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2012 | 3461 | 0.180 |
Why?
|
| Models, Statistical | 1 | 2014 | 5102 | 0.170 |
Why?
|
| Cardiovascular Agents | 2 | 2015 | 850 | 0.150 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5034 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 7913 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6487 | 0.130 |
Why?
|
| Myocarditis | 1 | 2023 | 771 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2014 | 23338 | 0.130 |
Why?
|
| Quality Improvement | 3 | 2015 | 3749 | 0.130 |
Why?
|
| Fee-for-Service Plans | 1 | 2018 | 694 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 1354 | 0.110 |
Why?
|
| Community Mental Health Services | 1 | 2015 | 386 | 0.100 |
Why?
|
| Incidental Findings | 1 | 2014 | 689 | 0.080 |
Why?
|
| Logistic Models | 2 | 2015 | 13408 | 0.080 |
Why?
|
| Endpoint Determination | 1 | 2012 | 601 | 0.080 |
Why?
|
| Career Choice | 1 | 2014 | 744 | 0.080 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 688 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1411 | 0.070 |
Why?
|
| Continuity of Patient Care | 1 | 2014 | 1049 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 2022 | 11727 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 19905 | 0.070 |
Why?
|
| Disabled Persons | 1 | 2015 | 1212 | 0.070 |
Why?
|
| Indazoles | 1 | 2007 | 289 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3508 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2018 | 3313 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.060 |
Why?
|
| Registries | 2 | 2023 | 8089 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2012 | 2110 | 0.060 |
Why?
|
| Survivors | 1 | 2015 | 2291 | 0.060 |
Why?
|
| Risk Factors | 4 | 2023 | 72290 | 0.060 |
Why?
|
| Sirolimus | 1 | 2012 | 1564 | 0.060 |
Why?
|
| Humans | 11 | 2023 | 744343 | 0.060 |
Why?
|
| Capillary Permeability | 1 | 2007 | 798 | 0.060 |
Why?
|
| Aged | 4 | 2018 | 163280 | 0.050 |
Why?
|
| Massachusetts | 1 | 2014 | 8663 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6538 | 0.050 |
Why?
|
| Imidazoles | 1 | 2007 | 1206 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7785 | 0.050 |
Why?
|
| Male | 6 | 2023 | 350118 | 0.040 |
Why?
|
| Female | 7 | 2023 | 380194 | 0.040 |
Why?
|
| Comorbidity | 1 | 2014 | 10388 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14722 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7279 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10262 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12245 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 12354 | 0.040 |
Why?
|
| Telemedicine | 1 | 2014 | 2872 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15165 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2635 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 20947 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 57776 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39050 | 0.030 |
Why?
|
| Health Plan Implementation | 1 | 2015 | 352 | 0.030 |
Why?
|
| Middle Aged | 2 | 2018 | 213383 | 0.020 |
Why?
|
| United States | 2 | 2015 | 69872 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 40075 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 53288 | 0.020 |
Why?
|
| Violence | 1 | 2015 | 909 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5317 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 63114 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2007 | 551 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 664 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2007 | 3689 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 35421 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 20822 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 5300 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10481 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 214055 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13695 | 0.000 |
Why?
|
| Mice | 1 | 2007 | 81183 | 0.000 |
Why?
|
| Animals | 1 | 2007 | 168757 | 0.000 |
Why?
|
Concepts
(92)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_